Insight Molecular Diagnostics (IMDX) EPS (Basic) Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) EPS (Basic) Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 10.71% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 59.25% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 36.90% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 59.35% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -6.64% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 17.24% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -8.41% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 18.33% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 28.13% |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | -1.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.99% |
| Mar 31, 2026 | -1.37% |
| Dec 31, 2025 | 70.62% |
| Sep 30, 2025 | 65.56% |
| Jun 30, 2025 | 14.64% |
| Mar 31, 2025 | 77.02% |
| Dec 31, 2024 | -47.83% |
| Sep 30, 2024 | -21.47% |
| Jun 30, 2024 | 66.64% |
| Mar 31, 2024 | -137,466.43% |
| Dec 31, 2023 | -205.74% |
| Sep 30, 2023 | 50.10% |
| Jun 30, 2023 | 27.86% |
| Mar 31, 2023 | 100.04% |
| Dec 31, 2022 | 120.32% |
| Sep 30, 2022 | 46.21% |
| Jun 30, 2022 | 36.65% |
| Mar 31, 2022 | -133.78% |
| Dec 31, 2021 | -298.74% |
| Sep 30, 2021 | -49.60% |